Table 10.
Factors addressed and confirmed by at least three papers
| THA | TKA | |
|---|---|---|
| Risk factors for VTE | 1. Older age | 1. TKA (vs. THA) |
| 2. Female sex | 2. Older age | |
| 3. Higher BMI | 3. Female sex | |
| 4. Bilateral surgery | 4. Higher BMI | |
| 5. VTE history | 5. Bilateral surgery | |
| 6. Surgery time > 2 hours | 6. Cemented fixation | |
| 7. Surgery time > 2 hours | ||
| Protective factors for VTE | 1. Chemoprophylaxis for VTE* | 1. Chemoprophylaxis for VTE* |
| 2. Enoxaparin (vs. other LMWH) | 2. Enoxaparin (vs. other LMWH) | |
| 3. Direct F-Xa inhibitor (vs. LMWH) | 3. Direct F-Xa inhibitor (vs. LMWH) | |
| 4. Earlier mobilization | ||
| Controversial factors for VTE | 1. Diabetes mellitus | 1. Diabetes mellitus |
| 2. Malignancy | 2. Malignancy | |
| 3. General anesthesia | 3. General anesthesia | |
| 4. ASA score | 4. VTE history | |
| 5. Varicose vein | ||
| 6. Hypertension | ||
| 7. Hormone replacement |
*Compared with no-prophylaxis patients.